SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tulvio Durand who wrote (946)7/8/1998 12:55:00 AM
From: M. Carver  Read Replies (3) of 1055
 
Thanks for the update. This is my first "post" to SI, although I have been reading these threads for awhile.

With respect to THRX, I spoke with their investor relations on 7/6. I like what I heard. They echoed what appeared in both the WSJ (7/6) and the Atlanta Constitution Business Section (lead article by Andy Miller on 7/4). Basically, the company feels the stock has been unduly punished and they effectively disputed the comments from the one analyst who started this mudslide.

In particular, I like Christine Jacobs (the CEO) comments to the Atlanta paper which included "she is confident her company will remain the leader in palladium, which she says kills cancer 3 times faster than iodine" and "We've got an 11-year head start in an industry with significant (regulatory) barriers to entry".

I certainly added more shares yesterday and look forward to comments from other shareholders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News